Published in:
01-04-2021 | Injectable Filler | Correction
Correction to: MD CodesTM: A Methodological Approach to Facial Aesthetic Treatment with Injectable Hyaluronic Acid Fillers
Published in: Aesthetic Plastic Surgery | Issue 2/2021
Login to get accessExcerpt
The author would like to correct Table 3. The corrected table appears here.
Table 3
MD Codes and Injection Guidance for Anatomical Sites Using Hyaluronic Acid Fillers
The volume shown in the Active Number column is the recommended volume for injection in one side of the face. For some codes, alternative injection guidance is given
ROOF, retro-orbicularis oculi fat; SMAS, superficial muscular aponeurotic system; SOOF, suborbicularis oculi fat; TML, top-model look
aRecommended volumes were determined based on the author’s clinical experience with Juvéderm injectables with Vycross technology, including Voluma with Lidocaine (Juvéderm Voluma XC), Volift with Lidocaine (Juvéderm Volift XC), and Volbella with Lidocaine (Juvéderm Volbella XC; all, Allergan plc, Dublin, Ireland)
bDo not inject into the cartilage or into the bone, but rather at the level of the cartilage or the level of the bone
cCk1 is the starting point of every injection with the MD Codes, and its active number is 0.1 + 0.1 + 0.1 mL. These three anchoring points are injected down to the bone to promote SMAS lifting. A single bolus of 0.3 mL in only one site is not advised here as it may bulge and look unnatural
dAspiration is highly recommended when injecting with a needle at the level of the bone
eAlthough the active number for C1 is 0.5 mL, when treatment of C1 is combined with C2, the active number for C1 becomes 0.7 mL so that the total volume for C1 + C2 = 1.0 mL (1 syringe). The same happens when Ck1 is combined with T1, Ck4, or Ck1 TML, and when Jw2 is combined with C5
fMainly used in male patients
gThis approach is for restoring forehead volume loss, forehead advancement, and forehead reshape
hTreatment of the forehead, eyebrow, glabella, and nose areas is very advanced and should only be delivered by highly trained experts with extensive injection experience and knowledge on the management of severe complications
iTear trough and orbital codes are reserved for specialists specifically trained in this technique and those who have a sound knowledge of the anatomy and physiology for this particular area
jInject slightly medial to the nasolabial crease
kThis treatment approach is designed to correct bone structural deficiencies
lThe use of cannulas in the nasolabial fold is advisable to correct dynamic nasolabial folds. The use of needles at the deep dermis/subdermal level may be used for the correction of fine lines
mFanning may be applied using needles in this area
nInject medially to the labial-mental crease
oSmall and low noses may be better addressed with cannulas
● = bolus, static injection of injectable (0.3 mL); 
= linear injection (anterograde or retrograde; 0.5 mL); 
= fanning, defined as multiple linear injections via a single entry site creating a fan-like pattern with cannulas (0.5 mL); 
= micro-aliquot injections of very small droplets of injectable (0.01–0.05 mL per point); 
= aliquot injections, defined as static injections of a small amount of injectable (0.1–0.2 mL)
= linear injection (anterograde or retrograde; 0.5 mL); = fanning, defined as multiple linear injections via a single entry site creating a fan-like pattern with cannulas (0.5 mL); = micro-aliquot injections of very small droplets of injectable (0.01–0.05 mL per point); = aliquot injections, defined as static injections of a small amount of injectable (0.1–0.2 mL)